Aarti Drugs Share Price
Small Cap | Pharmaceuticals and health care | NSE: AARTIDRUGS | BSE: 524348
₹322.40 
-7.90 (-2.39 %)
Last Updated: 09 Apr 2025 03:31 PM
BEARISH
Overview
Open (₹) 330.30
High (₹) 330.30
Low (₹) 320.20
Prev. Close (₹) 330.30
Volume 71,955
VWAP (₹) 357.48
ROCE (%) 16.43
Industry P/E 43.25
TTM P/E 19.28
P/B Ratio 2.31
Market Cap (₹) Cr.2,942.54
Dividend Yield (%)0.31
EPS (₹) 18.56
ROE13.31%
Sales Growth (%) -6.90
Profit Growth (%)3.15
Day Range
330.30330.30
52 Week Range
312.50634.90
Historical Returns
Returns (6M)
-36.72 %
Returns (1Y)
-36.53 %
Returns (3Y)
-37.71 %
Returns (5Y)
89.34 %
Returns (6M)
-36.72 %
Returns (1Y)
-36.53 %
Returns (3Y)
-37.71 %
Returns (5Y)
89.34 %
SWOT Analysis
- Company with (3.28%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 3.28% positive TTM EPS growth
- Growth in Net Profit Margin (QoQ)
Technicals
Technical Rating
BEARISHRSI 47.18
MFI 37.77
ATR 19.12
Commodity Channel Index -151.93
ROC125 -39.87
ROC21 -13.87
Williams %R -98.37
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 368.24 | 385.12 | 394.24 | 359.12 | 342.24 | 333.12 | 316.24 |
| Week Ago | 392.36 | 396.63 | 401.06 | 387.93 | 383.66 | 379.23 | 374.96 |
| Month Ago | 400.64 | 411.27 | 417.59 | 394.32 | 383.69 | 377.37 | 366.74 |
EMA & SMA
322.40
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 377.67
9 Day 379.62
10 Day 386.72
12 Day 384.77
14 Day 387.50
20 Day 396.45
26 Day 397.33
50 Day 417.30
100 Day 447.54
200 Day 484.01
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| MIRIK RAJENDRA GOGRI | bulk | Sell | 28 May, 2024 | ₹485.50 | 4,68,378 | NSE |
| BLEND FUND 2 | bulk | Buy | 28 May, 2024 | ₹484.97 | 5,11,571 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 18 Oct, 2023 | ₹554.70 | 4,80,077 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 18 Oct, 2023 | ₹554.17 | 4,80,077 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 25 Jul, 2023 | ₹628.40 | 9,33,060 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 25 Jul, 2023 | ₹627.89 | 9,33,060 | NSE |
| QE SECURITIES | bulk | Sell | 24 Jul, 2023 | ₹587.73 | 5,05,851 | NSE |
| NK SECURITIES RESEARCH PRIVATE LIMITED | bulk | Sell | 24 Jul, 2023 | ₹588.59 | 5,53,535 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 24 Jul, 2023 | ₹576.46 | 6,43,754 | NSE |
| QE SECURITIES | bulk | Buy | 24 Jul, 2023 | ₹587.77 | 4,97,273 | NSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 03 Apr, 2022 | Renil Rajendra Gogri | Disposal | ₹438.13 | 1,64,500 | NSE |
| 03 Apr, 2022 | Harit Pragji Shah | Acquisition | ₹440.78 | 25,000 | NSE |
| 03 Apr, 2022 | ALCHEMIE FINSERV PRIVATE LIMITED | Acquisition | ₹437.21 | 53,500 | NSE |
| 03 Apr, 2022 | Prakash Moreshwar Patil | Acquisition | ₹440.73 | 50,000 | NSE |
| 03 Apr, 2022 | Seema Harshit Savla | Acquisition | ₹440.78 | 11,000 | NSE |
| 03 Apr, 2022 | Harshit Manilal Savla | Acquisition | ₹440.78 | 14,000 | NSE |
| 01 Apr, 2022 | Renil Rajendra Gogri | Disposal | ₹439.28 | 1,80,615 | NSE |
| 01 Apr, 2022 | RASHESH CHANDRAKANT GOGRI | Acquisition | ₹440.54 | 1,20,000 | NSE |
| 01 Apr, 2022 | ALCHEMIE FINSERV PRIVATE LIMITED | Acquisition | ₹438.95 | 70,000 | NSE |
| 08 Mar, 2022 | Arun Moreshwar Patil | Acquisition | ₹459.35 | 609 | NSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 29 Jan, 2025 | Rs.1.0000 per share(10%)Interim Dividend | 04 Feb, 2025 | 04 Feb, 2025 |
| 24 Jan, 2024 | Rs.1.0000 per share(10%)Interim Dividend | 06 Feb, 2024 | 06 Feb, 2024 |
| 27 Jan, 2023 | Rs.1.0000 per share(10%)Interim Dividend | 08 Feb, 2023 | 08 Feb, 2023 |
| 20 Aug, 2020 | Bonus issue in the ratio of 3:1.of Rs.10 /- each. | 30 Sept, 2020 | 01 Oct, 2020 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 08 Apr, 2025 | NSE India | Aarti Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
| 08 Apr, 2025 | BSE India | Certificate under Re. 74(5) of SEBI (DP) Regulations, 2018 |
| 02 Apr, 2025 | NSE India | Aarti Drugs Limited has informed the Exchange about Action(s) taken or orders passed |
| 02 Apr, 2025 | BSE India | Disclosure under Regulation 30 of SEBI Listing Regulations - Cautionary letter from Stock Exchange. |
| 29 Mar, 2025 | NSE India | AARTI DRUGS LIMITED has informed the Exchange about Closure of Trading Window |
| 29 Mar, 2025 | NSE India | Aarti Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 17 Mar, 2025 | NSE India | Aarti Drugs Limited has informed the Exchange about Schedule of meet |
| 17 Mar, 2025 | BSE India | Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. |
| 11 Mar, 2025 | NSE India | Aarti Drugs Limited has informed the Exchange about Cancellation of Schedule of Analyst / Institutional Investor Meetings. |
| 11 Mar, 2025 | BSE India | Cancellation of Schedule of Analyst / Institutional Investor Meetings. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Interim Dividend | -- | 23 Jan, 2025 | 29 Jan, 2025 |
| Quarterly Results | -- | 17 Oct, 2024 | 24 Oct, 2024 |
| Buy Back of Shares | -- | 22 Aug, 2024 | 26 Aug, 2024 |
| Quarterly Results | -- | 22 Jul, 2024 | 26 Jul, 2024 |
| Audited Results | -- | 29 Apr, 2024 | 03 May, 2024 |
| Quarterly Results & Interim Dividend | -- | 18 Jan, 2024 | 24 Jan, 2024 |
| Quarterly Results | -- | 13 Oct, 2023 | 19 Oct, 2023 |
| Quarterly Results & Buy Back | -- | 18 Jul, 2023 | 21 Jul, 2023 |
| Audited Results | -- | 25 Apr, 2023 | 29 Apr, 2023 |
| Quarterly Results & Interim Dividend | -- | 23 Jan, 2023 | 27 Jan, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
|---|---|---|---|---|---|
| Promoter Group | 55.38% | 57.47% | 59.66% | 59.99% | 60.2% |
| Foreign Institutions + | 2.28% | 2.1% | 1.9% | 2.03% | 3.06% |
| Domestic Institutions + | 8.77% | 5.26% | 3.9% | 2.28% | 1.67% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 33.57% | 35.17% | 34.54% | 35.7% | 35.07% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Aarti Drugs
Aarti Drugs is a Public Limited Listed company incorporated on 28/09/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L37060MH1984PLC055433 and registration number is 055433. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 2266.91 Cr. and Equity Capital is Rs. 91.94 Cr. for the Year ended 31/03/2024.
Parent Organisation
Aarti Group
Founded
1984
Managing Director
Mr. Rashesh C Gogri
NSE Symbol
AARTIDRUGS
Aarti Drugs Management
| Name | Designation |
|---|---|
| Mr. Chandrakant V Gogri | Chairman Emeritus |
| Mr. Prakash M Patil | Chairman & M.D & CEO |
| Mr. Rashesh C Gogri | Managing Director |
| Mr. Harshit M Savla | Joint Managing Director |
| Mr. Harit P Shah | Executive Director |
| Mr. Uday M Patil | Executive Director |
| Mr. Narendra J Salvi | Non Executive Director |
| Mr. Ankit V Paleja | Independent Director |
| Prof. Bhaskar N Thorat | Independent Director |
| Mrs. Neha R Gada | Independent Director |
| Mr. Hasmukh B Dedhia | Independent Director |
| Mr. Sandeep M Joshi | Independent Director |
| Mr. Ajit E Venugopalan | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹3,96,418.12 | ₹1,652.20  ₹1,688.35(-2.14%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,42,985.36 | ₹5,386.15 ₹5,387.30(-0.02%) | ₹3,640.100 - ₹6,448.750 |
| Cipla | ₹1,14,326.28 | ₹1,415.60 ₹1,432.55(-1.18%) | ₹1,310.050 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,05,825.12 | ₹3,126.80 ₹3,246.60(-3.69%) | ₹2,508.650 - ₹3,589.950 |
| Mankind Pharma | ₹95,468.61 | ₹2,313.95 ₹2,347.50(-1.43%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Aarti Drugs
What is the share price of Aarti Drugs?
The share price of Aarti Drugs on 09 Apr, 2025 is ₹ 322.40.
What is 52W high and 52W low share price of Aarti Drugs?
The highest and lowest 52W share prices of Aarti Drugs are ₹ 634.900 and ₹ 312.500
What is the market cap of Aarti Drugs?
The market capitalization of Aarti Drugs as of 09 Apr, 2025 is ₹ 2,942.54 Crores
What is the P/E ratio of Aarti Drugs?
The current P/E ratio of Aarti Drugs as of 09 Apr, 2025 is 43.25
What is the PB ratio of Aarti Drugs?
The PB ratio of Aarti Drugs as of 09 Apr, 2025 is 2.31
Top Gainers
₹36.24
₹30.20 (0.20%)
₹697.45
₹584.85 (0.19%)
₹36.52
₹30.44 (0.20%)
₹14.76
₹12.30 (0.20%)
Top Losers
₹0.84
₹0.95 (-0.12%)
₹4.85
₹5.38 (-0.10%)
₹1.51
₹1.74 (-0.13%)
₹316.80
₹360.00 (-0.12%)
Market Indices
Sensex
₹73,847.15
₹74,227.08 (-0.01%)